The Johnson & Johnson coronavirus vaccine has been shown to be 66 per cent effective at preventing moderate to severe illness, according to data from a phase-3 clinical trial.
undefined subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.
Share this post
Johnson & Johnson’s jab could be a lifeline…
Share this post
The Johnson & Johnson coronavirus vaccine has been shown to be 66 per cent effective at preventing moderate to severe illness, according to data from a phase-3 clinical trial.